TargetMol

DE 2

Product Code:
 
TAR-T31237
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31237-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
DE 2 is a biochemical.
CAS:
17409-50-6
Formula:
C9H12Cl3N3Zn
Molecular Weight:
333.95
Purity:
0.98
SMILES:
[Cl-].[Cl-].[Cl-].[Zn++].CCNc1ccc(cc1C)[N+]#N

References

1. Mangelsdorff G, Cuevas P, Rodriguez JR, Pereira N, Ramirez E, Ya?ez R. Reduced Anterolateral Thigh Flap Donor-Site Morbidity Using Incisional Negative Pressure Therapy. J Reconstr Microsurg. 2018 Sep 27. doi: 10.1055/s-0038-1672126. [Epub ahead of print] PubMed PMID: 30261526. 2. Scotece M, Conde J, Abella V, L?pez V, Francisco V, Ruiz C, Campos V, Lago F, Gomez R, Pino J, Gualillo O. Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-?B Pathways. Cell Physiol Biochem. 2018 Sep 27;49(6):2414-2426. doi: 10.1159/000493840. [Epub ahead of print] PubMed PMID: 30261513. 3. Fourier A, Formaglio M, Sauv?e M, Perret-Liaudet A, Latour P, Bost M, Quadrio I. C9orf72 Protein Plasmatic Concentrations Are Similar between C9ORF72 Expansion Carriers and Noncarriers in Frontotemporal Dementia. Dement Geriatr Cogn Disord. 2018 Sep 27;46(3-4):180-185. doi: 10.1159/000492963. [Epub ahead of print] PubMed PMID: 30261505. 4. Sarret C, Lemaire JJ, Sontheimer A, Coste J, Savy N, Pereira B, Roche B, Boespflug-Tanguy O. Brain Diffusion Imaging and Tractography to Distinguish Clinical Severity of Human PLP1-Related Disorders. Dev Neurosci. 2018 Sep 27:1-11. doi: 10.1159/000492218. [Epub ahead of print] PubMed PMID: 30261498.